HomeCTNM • NASDAQ
add
Contineum Therapeutics Inc
Previous close
$14.34
Day range
$13.92 - $14.82
Year range
$12.33 - $21.92
Market cap
363.21M USD
Avg Volume
73.32K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 12.97M | 60.79% |
Net income | -10.27M | -64.25% |
Net profit margin | — | — |
Earnings per share | -0.40 | — |
EBITDA | -12.91M | -60.88% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 213.91M | 58.31% |
Total assets | 216.03M | 55.37% |
Total liabilities | 5.81M | -23.29% |
Total equity | 210.23M | — |
Shares outstanding | 25.78M | — |
Price to book | 1.76 | — |
Return on assets | -14.83% | — |
Return on capital | -15.12% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -10.27M | -64.25% |
Cash from operations | -6.17M | -14.73% |
Cash from investing | -30.18M | 23.58% |
Cash from financing | 13.00K | -99.87% |
Net change in cash | -36.34M | -5.18% |
Free cash flow | -3.43M | — |
About
Founded
2009
Website
Employees
31
